Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
- PMID: 30209082
- DOI: 10.1136/bjophthalmol-2018-312068
Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Abstract
Background: To assess the prevalence and causes of vision impairment in North Africa and the Middle East (NAME) from 1990 to 2015 and to forecast projections for 2020.
Methods: Based on a systematic review of medical literature, the prevalence of blindness (presenting visual acuity (PVA) <3/60 in the better eye), moderate and severe vision impairment (MSVI; PVA <6/18 but ≥3/60) and mild vision impairment (PVA <6/12 but ≥6/18) was estimated for 2015 and 2020.
Results: The age-standardised prevalence of blindness and MSVI for all ages and genders decreased from 1990 to 2015, from 1.72 (0.53-3.13) to 0.95% (0.32%-1.71%), and from 6.66 (3.09-10.69) to 4.62% (2.21%-7.33%), respectively, with slightly higher figures for women than men. Cataract was the most common cause of blindness in 1990 and 2015, followed by uncorrected refractive error. Uncorrected refractive error was the leading cause of MSVI in the NAME region in 1990 and 2015, followed by cataract. A reduction in the proportions of blindness and MSVI due to cataract, corneal opacity and trachoma is predicted by 2020. Conversely, an increase in the proportion of blindness attributable to uncorrected refractive error, glaucoma, age-related macular degeneration and diabetic retinopathy is expected.
Conclusions: In 2015 cataract and uncorrected refractive error were the major causes of vision loss in the NAME region. Proportions of vision impairment from cataract, corneal opacity and trachoma are expected to decrease by 2020, and those from uncorrected refractive error, glaucoma, diabetic retinopathy and age-related macular degeneration are predicted to increase by 2020.
Keywords: North Africa and the Middle East; blindness; cataract; epidemiology; uncorrected refractive error; vision impairment.
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: JBJ: consultant for Mundipharma (Cambridge, UK); patent holder with Biocompatibles UK (Farnham, Surrey, UK) (Title: Treatment of eye diseases using encapsulated cells encoding and secreting neuroprotective factor and/or antiangiogenic factor; patent number: 20120263794) and patent application with the University of Heidelberg (Heidelberg, Germany) (Title: Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia; Europäische Patentanmeldung 15 000 771.4). JHK: consultant for Gilead and Santen. SR: consultant for Brien Holden Vision Institute.
Similar articles
-
Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections.Br J Ophthalmol. 2019 Jul;103(7):878-884. doi: 10.1136/bjophthalmol-2018-311946. Epub 2018 Sep 12. Br J Ophthalmol. 2019. PMID: 30209084
-
Causes of vision loss worldwide, 1990-2010: a systematic analysis.Lancet Glob Health. 2013 Dec;1(6):e339-49. doi: 10.1016/S2214-109X(13)70113-X. Epub 2013 Nov 11. Lancet Glob Health. 2013. PMID: 25104599 Review.
-
Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections.Br J Ophthalmol. 2020 May;104(5):616-622. doi: 10.1136/bjophthalmol-2018-313308. Epub 2019 Aug 28. Br J Ophthalmol. 2020. PMID: 31462416
-
Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections.Br J Ophthalmol. 2018 May;102(5):575-585. doi: 10.1136/bjophthalmol-2017-311258. Epub 2018 Mar 15. Br J Ophthalmol. 2018. PMID: 29545417 Free PMC article.
-
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1. Lancet Glob Health. 2021. PMID: 33275949 Free PMC article.
Cited by
-
Adults visual impairment and blindness - An overview of prevalence and causes in Saudi Arabia.Saudi J Ophthalmol. 2019 Oct-Dec;33(4):374-381. doi: 10.1016/j.sjopt.2019.10.001. Epub 2019 Nov 7. Saudi J Ophthalmol. 2019. PMID: 31920448 Free PMC article.
-
Global Ophthalmology in the Middle East: a Task Force proposal.Eye (Lond). 2024 Aug;38(11):1986-1987. doi: 10.1038/s41433-024-03020-5. Epub 2024 Mar 14. Eye (Lond). 2024. PMID: 38486118 Free PMC article. No abstract available.
-
Age-Related Macular Degeneration Prevalence and its Risk Factors in Iran: A Systematic Review and Meta-Analysis Study.J Curr Ophthalmol. 2024 Aug 10;35(4):305-312. doi: 10.4103/joco.joco_40_23. eCollection 2023 Oct-Dec. J Curr Ophthalmol. 2024. PMID: 39281400 Free PMC article. Review.
-
Prevalence Rates and Risk Factors for Primary Open Angle Glaucoma in the Middle East.J Ophthalmic Vis Res. 2021 Oct 25;16(4):644-656. doi: 10.18502/jovr.v16i4.9755. eCollection 2021 Oct-Dec. J Ophthalmic Vis Res. 2021. PMID: 34840687 Free PMC article. Review.
-
Effect of intraocular lens implantation on visual field in glaucoma and comorbid cataracts.Int J Ophthalmol. 2020 Apr 18;13(4):580-586. doi: 10.18240/ijo.2020.04.08. eCollection 2020. Int J Ophthalmol. 2020. PMID: 32399408 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous